European Stock Markets
The latest news, updates and opinions on European Stock Markets from the expert team here at MoneyWeek
Latest
-
Equity investors should look to Europe for growth
Advice In the scramble for alternative to overpriced US stocks, investors could do worse than look at European equities.
By Alex Rankine Published
Advice -
Is it time to buy Europe and sell the US?
Opinion Europe is looking ever more attractive to investors, while the US is starting to look like the riskier bet, says John Stepek.
By John Stepek Published
Opinion -
What exactly is going on in the Wirecard scandal?
Briefings Wirecard, a darling of the German fintech sector, has collapsed and its boss has been charged with fraud. Red flags have waved for years, yet the regulators went for the flag bearers. What went wrong?
By Simon Wilson Published
Briefings -
What's behind the wipeout at Wirecard?
News Wirecard, the German blue-chip technology group that specialised in payment-processing, has collapsed in scandal. Matthew Partridge reports.
By Dr Matthew Partridge Published
News -
European assets bounce as the eurozone's economy turns upwards
News Both the euro and European stocks have rallied strongly in the last few days.
By Alex Rankine Published
News -
European stocks are due a rebound
News European stockmarkets were cheered by the announcement of a Franc-German plan to issue a common European bond, which came as lockdowns were eased in many parts of the continent.
By Alex Rankine Published
News -
Coronavirus has created a toxic backdrop for Russian stocks
News Russia's stockmarket is down by about 13% since the start of 2020, with the country having the world’s third-highest number of confirmed cases opf Covid-19.
By Alex Rankine Published
News -
Don’t write off European stocks
News The Eurozone economy may have slowed to a crawl, but a return to earnings growth has given investors in European stocks hope.
By moneyweek Published
News -
Is Bayer a bargain stock despite the litigation surrounding Roundup?
News The German chemicals group Bayer’s lawsuits over its Roundup weedkiller could throttle its profits. But is the gloom overdone? Matthew Partridge reports
By Dr Matthew Partridge Published
News